Solomax is an innovative platform designed to enhance healthcare in the field of cardiovascular diseases. Developed with the support of the MEF, it represents a significant step forward in the digitalization of healthcare. The platform is the result of close collaboration between Innovaway, the University of Salerno (Unisa), Ericsson, Beyond, and Clinica Minerva. Innovaway, headquartered in Naples, leads the project.

"Solomax represents an important evolution in our mission to improve health through technological innovation," explains Antonio Giacomini, CEO of Innovaway. "This platform not only facilitates the management of cardiovascular diseases but also opens new possibilities for a more inclusive and personalized healthcare system. We are excited to see how Solomax can practically improve the lives of patients through more precise diagnoses, timely therapies, and continuous management of health conditions."

What does the platform actually do?

Solomax serves as an information-sharing center that unites all the actors involved in the healthcare process, including blog therapy sessions to encourage the exchange of experiences and support among patients. It is equipped with a Symptom Checker, a search engine that helps patients identify symptoms and direct them to the most appropriate healthcare professional.

The platform also incorporates artificial intelligence, offering services such as Telemedicine, Televisits, and Teleconsultations. These advanced services ensure continuous and personalized health monitoring, making remote healthcare more accessible and efficient.

An important feature is the Mobile App, which continuously monitors the patient, enabling constant health tracking and enhancing the overall patient experience.

Solomax is truly a leap forward in digital healthcare, bringing advanced technologies together to improve the diagnosis, treatment, and management of cardiovascular diseases, while offering patients more accessible, inclusive, and tailored care.